Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium

Pasqualini, Claudia ; Rubino, Jonathan ; Brard, Caroline ; Cassard, Lydie ; André, Nicolas ; Rondof, Windy ; Scoazec, Jean-Yves ; Marchais, Antonin ; Nebchi, Souad ; Boselli, Lisa ; Grivel, Jonathan ; Aerts, Isabelle ; Thebaud, Estelle ; Paoletti, Xavier ; Minard-Colin, Véronique ; Vassal, Gilles ; Geoerger, Birgit

European journal of cancer (1990), 2021-06, Vol.150, p.53-62 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível